News | News By Subject | News by Disease News By Date | Search News

Infection/Antibiotics News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Warp Drive Bio Hands Over Antibiotics Program to Sanofi (SNY)     11/30/2016
Tiny Dipexium (DPRX) Craters After Lead Drug Locilex Flunks Phase III Trials     10/25/2016
A Closer Look at the Pipelines Pfizer (PFE) Inherited From Recent Acquisitions     10/5/2016
Basilea (BSLN.SW) Ends Further Development of Inhaled Antibiotic BAL30072     8/15/2016
Seres Therapeutics (MCRB) Craters in Phase II ECOSPOR Study; CEO and Execs Profit on Insider Sales     7/29/2016
Gilead (GILD)'s Odefsey Successful in Two Phase IIIb Studies     7/22/2016
Amid Trial Concerns, FDA Delays Approval Decision for Merck & Co. (MRK)'s C. Diff Drug, New PDUFA Date Set     7/22/2016
FDA Spurns Novartis AG (NVS)'s Copy of Amgen (AMGN) Blockbuster Neulasta     7/19/2016
FDA Advisors Backs Approval for Merck & Co. (MRK)'s Infectious Diarrhea Drug     6/10/2016
FDA Questions Merck & Co. (MRK)'s C. Diff Diarrhea Medication’s Efficacy     6/8/2016
FDA Warns Against Off-Label Use of Johnson & Johnson (JNJ)'s Nizoral Tablets to Treat Skin And Nail Infections, Linked to Patient Death     5/20/2016
TetraPhase (TTPH) Drops After the FDA Requests More Data for Eravacycline NDA Submission     5/13/2016
More Bad News for Chimerix (CMRX) as Brincidofovir Fails Another Late Stage Study     5/9/2016
Basilea (BSLN.SW) Wins $100 Million Contract to Fund Phase III Ceftobiprole Program     4/20/2016
Booming Seres Therapeutics Looks to Move Lead Product into Phase III, Expand in Cambridge     4/14/2016

News from Around the Web
LivaNova (LIVN) Plant Linked to Heart Surgery Infections From Contaminated Medical Devices     7/14/2017
Antibiotic Nanoparticles Fight Drug-Resistant Bacteria, Advanced Materials Reveals     7/13/2017
People Are Not Petri Dishes—New Study Shows Why Antibiotics Fail, University of California, Santa Barbara Reveals     7/5/2017
New Test Can ID Dangerous Bacteria With Resistance To Last-Resort Antibiotic, European Society of Clinical Microbiology and Infectious Diseases Reveals     4/24/2017
Can Maple Syrup Extract Make Antibiotics Kill Bacteria Easily? McGill University Study Reveals     4/5/2017
Common Antibiotic May Help To Prevent Or Treat PTSD, University of Zurich Study Reveals     4/4/2017
Who Is On The WHO's New Most Dangerous Superbugs List     2/28/2017
Woman Dies Of A Superbug Resistant To Every Antibiotic In The U.S., CDC Study     1/13/2017
From Click Chemistry To Antibiotic Spider Silk, University of Nottingham Study     1/9/2017
Portable Antibiotic Resistance Detector Developed, UCLA Study     12/27/2016
New Tool May Help Combat Antibiotic Resistance, University of Sheffield Study     11/1/2016
Scientists Are Freaking Out Over This 25-Year-Old's Solution To Superbugs, University Of Montreal Study     9/28/2016
Inside The 10-Year, $1 Billion Battle For The Next Critical Antibiotic     9/21/2016
Saving Antibiotics So That Antibiotics Can Save Lives     9/16/2016
Kids With Exposure To Antibiotics Linked To Allergies Later In Life, Utrecht University Study     9/6/2016

Press Releases
SCYNEXIS, Inc. (SCYX) Presents New Data Supporting Oral SCY-078 For The Clinical Treatment Of Vulvovaginal Candidiasis Infections At The 2017 IDSOG Annual Meeting     8/14/2017
Motif BioSciences, Inc.’s Second Phase III Clinical Trial In ABSSSI Finishes Patient Treatment Phase     8/9/2017
Wockhardt (WOCKHARDT.BO)'s Antibiotic Injection Gets U.S. FDA Approval     8/7/2017
Rebiotix Announces First Patient Enrolled In Phase III Clinical Trial Of RBX2660 For The Prevention Of Recurrent Clostridium Difficile Infection     8/7/2017
Dr. Reddy's Laboratories Ltd. (RDY)’s And CHD Bioscience Announce Global License And Commercialization Agreement For Phase III Clinical Trial Candidate For Mitigation Of Surgical Site Infections     7/27/2017
TetraPhase (TTPH) Announces Positive Top-Line Results From Phase III IGNITE4 Clinical Trial In Complicated Intra-Abdominal Infections     7/26/2017
The Medicines Company (MDCO) Announces TANGO-2 Trial Of Meropenem-Vaborbactam (Formerly, Carbavance) Stopped Early For Superior Benefit-Risk Compared To Best Available Therapy For CRE     7/25/2017
Achaogen (AKAO) Wins CARB-X Funding Award To Advance Development Of LpxC Inhibitor Antibiotic To Fight Drug Resistant Infections     7/25/2017
Iterum Gains Important Support For Development Of Novel Oral Antibiotic, Sulopenem     7/25/2017
Ra Pharma (RARX) Announces Publication Of Positive Preclinical Data With RA101295 For The Treatment Of Escherichia Coli Sepsis     7/20/2017
Recce (RCE) Achieves Milestone With Volume Production Of Antibiotic Compounds To Support Clinical Trials     7/20/2017
T2 Biosystems (TTOO) Receives CE Mark For T2Bacteria Panel Enabling Commercialization In Europe     7/18/2017
Lipocoat Developed Novel Biotech Coating To Prevent Bacterial Infections     7/14/2017
Ingenza Release: Consortium Secures Innovate Uk Funding For New Antibiotics     7/5/2017
Summit Therapeutics Presents Data From Phase I Clinical Programme Of Ezutromid At The EPNS Congress     6/22/2017